The efficacy of neoadjuvant chemotherapy in invasive bladder cancer

International Urology and Nephrology

Volumn 33, Issue 1, 2002, Pages 49-52

  Cam, K ^a   Yildirim, A ^a   Ozveri, H ^a   Turkeri, L ^a   Akdas, A ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Invasive bladder cancer; Neoadjuvant chemotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; METASTASIS; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; SURVIVAL RATE; ADJUVANT THERAPY; BLADDER TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROBABILITY; PROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROBABILITY; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TURKEY; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0036049399     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014496602067     Document Type: Article

References (19)

1. Cancer statistics, 1995
2. Current management of invasive and metastatic transitional cell carcinoma of the bladder
3. Superficial bladder cancer: Progression and recurrence
4. Surgical therapy for locally advanced bladder cancer
5. Contemporary cystectomy with pelvic lymph node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer
6. Bladder cancer as seen in giant sections
7. Management of invasive bladder neoplasms
8. Neoadjuvant chemotherapy of osteosarcoma: Results of randomized cooperative trial with salvage chemotherapy based on histological tumor response
9. Treatment of Wilm's Tumor: Results of third national Wilm's study
10. The predictive value of initial cytotoxic response in primary unresectable rhabdomysarcoma in children
11. Influence of the leukemic inoculum on the effectiveness of treatment
12. Tumor size, sensitivity to therapy and the design of treatment schedules
13. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors
14. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder. A prospective randomized phase III study
15. Does neoadjuvant cisplatin based chemotherapy improve survival of patients with locally advanced bladder cancer: A meta-analysis of individual patient data from randomized trials. Advanced bladder cancer overview collaboration
16. Neoadjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial
17. Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients treated with MVAC with a 5-year follow-up
18. The prognostic value of the pathological response to combination chemotherapy before cystecomy in patients with muscle invasive bladder cancer
19. The prognostic value of the pT category after combination chemotherapy for patients with muscle invasive bladder cancer who underwent cystectomy